Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Pitt, B., Zannad, F. M., Remme, W. J., Cody, R. J., Castaigne, A., Pérez, A. J. P., Palensky, J., & Wittes, J. T. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604

Fármacos antialdosterónicos: su papel en la insuficiencia cardíaca

Galve, E. (2008) · Medicina Clínica · doi:10.1157/13115024 · Cited by 1

The 10thAnnual Cardiometabolic Health Congress General Session Highlights

Cerrato, P. L., & Mihalovic, M. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1175236 · Cited by 1

Boosting the Limited Use of Mineralocorticoid Receptor Antagonists Through New Agents for Hyperkalemia

Athyros, V. G., Sachinidis, A. G., Zografou, I., Simoulidou, E., Piperidou, A., Stavropoulos, N., & Karagiannis, A. I. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190306162339 · Cited by 1

Cardio-renal insufficiency: the search for management strategies

Gil, P., Justo, S., Castilla, M. Á., Criado, C., & Caramelo, C. A. (2005) · Current Opinion in Internal Medicine · doi:10.1097/00132980-200512000-00008 · Cited by 1

Ferritin level and blood parameters in patients with hypertension and diabetes

Abdul-Razak, A. S., Alsharba, N., Neamah, N. F., & Qasim, Q. A. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s01.69 · Cited by 1

Development and validation of a predictive model for the assessment of potassium-lowering treatment among hyperkalemia patients

Song, C. (2023) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.1920-8642.2023.048 · Cited by 1

Electrolyte and Renal Disorders in the Critically Ill Elderly

Geller, D. S., & Crowley, S. T. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316676325.009 · Cited by 1

Changes in serum potassium with concomitant administration of renin-angiotensin system agents and potassium-sparing diuretics: U.S. cohort study using electronic health record data

Syeed, M. S., Gómez-Lumbreras, A., Tan, M. S., & Malone, D. C. (2023) · JAPhA Pharmacotherapy · doi:10.1016/j.japhar.2023.100002 · Cited by 1

Unconventional route of administration of sodium zirconium cyclosilicate via nasogastric tube: A case report

Iglesias, M. B., García, E. B., & Pedrinaci, E. Z. (2024) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2024.06.006 · Cited by 1

Introduction of Renin-Angiotensin-Aldosterone System (RAAS)

Nandave, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-7380-0_1 · Cited by 1

Dyskalemia Prior to and After Initiation of a Fixed Dose Combination of Telmisartan and Amlodipine in Adults with Hypertension in Bangladesh

Ishigami, J., Hasan, M. M., Sarker, A., Nahar, S., Shuvo, S. S., Ishraquzzaman, M., Mamun, M. A. A., Kalimuddin, M., Sobhan, S. M. M., Zhao, D., et al. (2025) · Global Heart · doi:10.5334/gh.1415 · Cited by 1

Bloqueadores del sistema renina angiotensina en pacientes con nefropatía por IgA: metanálisis de ensayos clínicos controlados

de la Torre, C. L., Mourelle, J. A. F., Heras, A. H., & Iglesias, J. M. (2010) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2010.06.002 · Cited by 1

Carpopedal spasm in an elderly woman

Singh, R. K. (2013) · Cureus · doi:10.7759/cureus.96 · Cited by 1

Pharmacotherapy for Hormone Excess in Adrenocortical Carcinoma

Auchus, R. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_23 · Cited by 1

Hyperkaliämie in der Präklinik

Berwanger, U., Conrad, D., & Armbruster, W. (2020) · Notfallmedizin up2date · doi:10.1055/a-1005-1618 · Cited by 1

The pharmacotherapeutic management of hyperkalemia in patients with cardiovascular disease

Tamargo, J. L., Caballero, R., & Delpón, E. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1891223 · Cited by 1

Implicaciones pronósticas de la hipo e hiperpotasemia en la insuficiencia cardíaca aguda con fracción de eyección reducida. Análisis de la mortalidad cardiovascular y reingresos hospitalarios

Laymito-Quispe, R. D. P., López‐Vilella, R., Sánchez-Lázaro, I. J., Trenado, V. J. D., Edo, S. L., Martínez‐Dolz, L., & Bonet, L. A. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2021.03.037 · Cited by 1

Association between serum potassium and risk of all‐cause mortality among chronic kidney diseases patients: A systematic review and dose–response meta‐analysis of more than one million participants

Sorraya, N., Farrokhzad, A., Hassani, B., & Talebi, S. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2478 · Cited by 1

Entgleisungen des Wasser- und Elektrolythaushaltes auf der Intensivstation

Matthäus, T., Schnitzler, R., Weithofer, P., Weber, M., & Merkel, F. (2006) · Der Internist · doi:10.1007/s00108-006-1718-4 · Cited by 1

Prognostic implications of hypo and hyperkalaemia in acute heart failure with reduced ejection fraction. Analysis of cardiovascular mortality and hospital readmissions

Laymito-Quispe, R. D. P., López‐Vilella, R., Sánchez-Lázaro, I. J., Trenado, V. J. D., Edo, S. L., Martínez‐Dolz, L., & Bonet, L. A. (2022) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2022.02.002 · Cited by 1

Enalapril

(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.00681-8 · Cited by 1

Reflections on the Role of the Professionalism Curriculum in Medical School

Fishman, M. L., Garfall, A. L., & Thomas, J. M. (2007) · The AMA Journal of Ethic · doi:10.1001/virtualmentor.2007.9.4.fred1-0704 · Cited by 1

Linking Lab and Pharmacy: Clinical Decision Support to Manage Inpatient Hyperkalemia

Yu, S. (2012) · Figshare · Cited by 1

Elektrolytstörungen bei Patienten mit Herzinsuffizienz

Rammer, M., Heibl, C., & Eber, B. (2008) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1

Besonderheiten der Pharmakotherapie beim älteren Hypertoniker

Kreutz, R. H. (2009) · Der Internist · doi:10.1007/s00108-008-2293-7 · Cited by 1

Prise en charge de l’hypertension artérielle d’origine rénale

Fesler, P., & Ribstein, J. (2006) · La Presse Médicale · doi:10.1016/s0755-4982(06)74748-0 · Cited by 1

Out-patient management of chronic heart failure

Terrovitis, J. V., ANASTASIOU‐NANA, M. I., & Nanas, J. N. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.11.1857 · Cited by 1

Tratamiento de la hipertensión arterial en la diabetes mellitus tipo 2

Teruel, J. L., Mateu, L. M. P., & Catalán, S. B. (2008) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(08)76268-5 · Cited by 1

A Janus-Headed Electrolyte and ‘RALES’ Disease’

Kraus, D., Wanner, C., & Kraus, B. J. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12173 · Cited by 1

Hyperkalemia: Newer Considerations

Bansal, A. D., & Goldfarb, D. S. (2007) · The AMA Journal of Ethic · doi:10.1001/virtualmentor.2007.9.4.cprl1-0704

Off-target effects of RAAS-inhibition: importance on renal outcomes in patients with diabetes

Yan, M. (2012) · University of Groningen research database (University of Groningen / Centre for Information Technology)

DisfunciÛn renal: f·rmacos, medios de contraste radiolÛgicos y sistema renina angiotensina Renal Impairment: Drugs, Radiocontrast Media and Renin-Angiotensin System

Cabrera, J. A. C., Echavarría, J. A. S., & Hernández, A. N. (2015) · DOAJ (DOAJ: Directory of Open Access Journals)

Does Integration of Laboratory Data Improve Prescribing Decisions and Patient Outcomes?

Bayoumi, I. (2012) · MacSphere (McMaster University) · doi:10.71548/17273

Aldosterone Antagonism in the Pharmacological Management of Chronic Heart Failure

Bozkurt, B. (2006) · Wiley eBooks · doi:10.1002/9780470994740.ch6

MONITORING OF POTASSIUM LEVEL ON THE HEART FAILURE PATIENTS USING CAPTOPRIL AND FUROSEMIDE

Titi Agni, H., Suharjono, S., & Aminuddin, M. (2013) · Universitas Airlangga Repository (Universitas Airlangga)

20 Antihypertensive drugs

Coleman, J. J. (2007) · Side effects of drugs annual · doi:10.1016/s0378-6080(06)29020-2

Metformina no tratamento da infertilidade na síndrome do ovário poliquístico

Moreira, A. R. D. S. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

Cardio-renal insufficiency: the search for management strategies

Gil, P., Justo, S., Castilla, M. Á., Criado, C., & Caramelo, C. A. (2005) · Current Opinion in Internal Medicine · doi:10.1097/00132980-200510000-00007

Preferred treatment of hyperkalemia

Rice, T. L., & Palevsky, P. M. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050411

Étude prospective observationnelle des hyperkaliémies secondaires aux inhibiteurs de l’enzyme de conversion chez des patients ayant une maladie rénale chronique hospitalisés

Mahmoud, L. B., Ghozzi, H., Kammoun, K., Hakim, A., Kharrat, M., Hmida, M. B., Jarraya, F., Sahnoun, Z., Zeghal, K. M., & Hachicha, J. (2012) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2012.09.001

Can we use mineralocorticoid receptor blockade in diabetic patients with resistant hypertension? Yes we can! But it may be a double-edged sword

Azizi, M., Monge, M., Lorthioir, A., Bobrie, G., & Amar, L. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328364bcdf

PS1-24: The Positive Predictive Value of a Hyperkalemia Diagnosis in Automated Health Care Data

Raebel, M. A., Ross, C., Smith, M., Saylor, G., Wright, L., Cheetham, C., Blanchette, C. M., & Xu, S. (2010) · Clinical Medicine & Research · doi:10.3121/cmr.2010.943.ps1-24

Herz und Niere

Dendorfer, U., & Mann, J. F. E. (2005) · CME · doi:10.1007/s11298-004-0006-7

Potential drug interactions : exposure and management in hospital and ambulatory settings

Indermitte, J. (2006) · edoc (University of Basel) · doi:10.5451/unibas-004088495

Rizikové kombinácie kardiovaskulárnych liečiv u starších pacientov a faktory zvyšujúce pravdepodobnosť ich výskytu

Wawruch, M. (2009) · Klinická farmakologie a farmacie

INCIDENT HYPERKALEMIA IS AN INDEPENDENT THERAPEUTIC TARGET IN LOW EJECTION FRACTION HEART FAILURE PATIENTS. INSIGHTS FROM THE HEAAL STUDY

Rossignol, P., Dobre, D., Gregory, D., Massaro, J., Kiernan, M., Konstam, M. A., & Zannad, F. M. (2012) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(12)60890-0

Renal Disease Following Hematopoietic Stem Cell Transplantation

Wanchoo, R., & Lam, A. Q. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2659-6_11

HEART FAILURE AND DIABETES MELLITUS: WHO SHOULD BE IN CHARGE ?

Dan, R., Petrescu, L., Timar, R. Z., & Dragulescu, S. I. (2009)

Enhancing drug safety through active surveillance of observational healthcare data

Ryan, P. B. (2019) · ProQuest Demo Repository · doi:10.17615/y9re-3w33

How to Use Inhibitors of the Renin-Angiotensin-Aldosterone System in Patients with CKD and Heart Failure

Gaiță, D. I., Moșteoru, S., & Segall, L. (2014) · Springer eBooks · doi:10.1007/978-3-319-09162-4_15

A case of severe hyperkalaemia presenting with cardiac arrythmias: An uncommon initial manifestation of chronic kidney disease

Sudusinghe, D. H., & Indrakumar, J. (2015) · Journal Of The Postgraduate Institute of Medicine · doi:10.4038/jpgim.8063

Foreign Article Review: Rates of Hyperkalemia after Publication of the Randomized Aldosterone Evaluation Study

Komatu, Y. (2005) · Japanese journal of pediatric nephrology · doi:10.3165/jjpn.18.156

Prevalence of Hyperkalemia in Type 2 Diabetics Treated with Inhibitors of the Renin-Angiotensin-Aldosterone System: A Multicenter Study

Saweer, A. A. (2016) · Journal of Surgery · doi:10.11648/j.js.s.2016040201.12

Effects of Garlic extracts on the myocardium of left ventricle of the heart of high salt fed adult wistar rats

Saka, O. S., Olayode, A., & Adelodun, S. (2016) · Pharmatutor

Wat te doen bij hyperkaliëmie veroorzaakt door RAAS-remmers?

Vingerhoeds, A. C. M. (2005) · Medisch-Farmaceutische Mededelingen · doi:10.1007/bf03058515

Hyperkalemia and hypokalemia

Manitius, J. (2011)

Combined blockade of the renin-angiotensin system Key-words (Index medicus): Renin. Hypertension. Diabetes Mellitus. Cardio- vascular Diseases

Azizi, M. (2014)

Blocage combiné du système rénine angiotensine

Azizi, M. (2014) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31347-0

Nutritional Strategies for the Patient with Diabetic Nephropathy

Vassalotti, J. A. (2006) · Nutrition and disease prevention · doi:10.1201/9781420014884.ch10

Off-target effects of RAAS-inhibition

Yan, M. (2012)

Biomarkers and assessment of drug efficacy in cardiovascular disease

Smink, P. A. (2013) · University of Groningen research database (University of Groningen / Centre for Information Technology)

Acid-Base and Electrolyte Imbalance in the Neurology Field

Yang, C. W. (2010)

Safety issues related to the use of prescription drugs in patients with chronic diseases: a bibliographic review

López, A. P., Fernández, M. J. M., Jiménez‐Heredia, M., & Calabuig, V. S. (2017) · Drugs & Therapy Perspectives · doi:10.1007/s40267-016-0371-9

신경과 영역에서 산-염기 및 전해질 불균형

양철우 (2011)

Assessment of adverse drug reactions of angiotensin converting enzyme (ace) inhibitors and angiotensin receptor blockers (arbs) among sudanese patients

Abdelazeim, A. A., Mohamed, A. N., & Mudawi, M. M. E. (2017) · International Journal of Current Advanced Research · doi:10.24327/ijcar.2017.3926.0398

Why kidney disease always gets worse: what can we do about it?

Lu, C. Y. (2014)

ACID-BASE AND ELECTROLYTE TEACHING CASE A Physiologic-Based Approach to the Evaluation of a Patient With Hyperkalemia

Palmer, B. F. (2010)

The effect of renin-angiotensin system blockades on renal protection in chronic kidney disease patients with hyperkalemia

이주현 (2013) · YUHSpace (Yonsei University Medical Library)

Niereninsuffizienz und Diabetes: vorausschauend handeln

Zanchi, A., Cherpillod, A., Pitteloud, N., Burnier, M., & Pruijm, M. T. (2014) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2014.01761

Concept and therapeutic approach to cardiorenal insufficiency

Otašević, P. (2012) · Srce i krvni sudovi · doi:10.5937/siks1201007o

NEW TREATMENT INSIGHTS OF HYPERKALEMIA ASSOCIATED TO CHRONIC KIDNEY DISEASE

Fasie, D. (2018) · SGEM International Multidisciplinary Scientific Conferences on Social Sciences and Arts · doi:10.5593/sgemsocial2018/3.3/s12.060

Iperkalemia cronica nei pazienti cardio – renali: q & a per il cardionefrologo pratico

Lullo, L. D., Ronco, C., Floccari, F., Pascalis, A. D., Bàrbera, V., Rivera, R. F., & Bellasi, A. (2018) · Giornale di Techniche Nefrologiche e Dialitiche · doi:10.1177/0394936218823520

Potassium Disorders

Sotirakopoulos, A. J., & Ross, S. J. (2011) · Wiley eBooks · doi:10.1002/9781118785546.ch62

Laboratory medicine in primary care Monitoring renal function in hypertension

Martin, U., & Coleman, J. J. (2007) · BMJ · doi:10.1136/sbmj.0706231

Clinical profile of dyselectrolytemia in diabetic patients in ICU at admission and its correlation with outcome

Pandey, A. K., Naithani, A., & Bagga, A. (2018) · Panacea Journal of Medical Sciences · doi:10.18231/2348-7682.2018.0026

Study of Serum Electrolyte Levels in Type 2 Diabetes Mellitus

Siddiqui, A. M., & Choudhary, S. K. (2019) · International Journal of Innovative Research in Medical Science · doi:10.23958/ijirms/vol04-i06/670

Análise de componentes do sistema renina-angiotensina-aldosterona em cães com doença renal crônica

Coelho, M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.74.2019.tde-22082019-153127

Effect of Antihypertensive Agents on Biochemical Parameters in Diabetic Patients in Taif - KSA

Daoud, N. M., Omar, A.-T. D., Kamal, A.-S. H., & Abdulrhman, Q. O. (2019) · International Journal of Diabetes and Clinical Research · doi:10.23937/2377-3634/1410113

Arterielle Hypertonie und Elektrolytstörungen

Rammer, M., Weber, T., Laßnig, E., Porodko, M., Ammer, M., & Eber, B. (2009) · Journal für Kardiologie (Krause & Pachernegg GmbH)

Kalium

Marino, P. L. (2017) · Elsevier eBooks · doi:10.1016/b978-3-437-23162-9.00036-6

Angiotensin-Converting Enzyme Inhibitors

Sica, D. A. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3053-9.50026-3

Study of Electrolyte Profile Levels in Hypoglycemic Diabetic Mellitus in Tertiary Care Hospital

Verma, P., Verma, S., & Jaiswal, S. (2019) · Asian Journal of Medical Research · doi:10.21276/ajmr.2019.8.3.bc2

Kidney Excretions: The Lyter Side of Urine

Steinman, J. R., Kuehn, C., & Antes, L. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-29138-9_15

Study of Serum Biomarkers in Females Hemodialysis Patients

Al-Ali, B. T. S. (2020) · BASRA JOURNAL OF SCIENCE · doi:10.29072/basjs.2020210

Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction

O’Donovan, K. (2020) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2020.0046

"Successful Resuscitation of an Elderly Diabetic Patient Having Life Threatening Acute Severe Hyperkalemia"

Sathi, S. (2020) · Annals of Urology & Nephrology · doi:10.33552/aun.2020.02.000527

Comparing the effect of insulin infusion alone and in combination of insulin infusion with salbutamol nebulization in treatment of hyperkalemia in diabetic and non-diabetic patients

Tiwari, R., Nain, P., Kaur, J., Rao, H. K., & Kaur, J. (2021) · Clinical and Experimental Health Sciences · doi:10.33808/clinexphealthsci.747900

Assessment of Predictors of Hyperkalemia in Cardiovascular Diseased Patients

Manasa, R., Johnson, A., Augustine, P. T., & Tom, A. M. (2021) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v11i2.4587

Sacubitril/valsartan: from the PARADIGM-HF trial results to heart failure patients in internal medicine. A narrative review

Verdiani, V. (2021) · Italian Journal of Medicine · doi:10.4081/itjm.2021.1347

Hyperkaliämie

Reith, S., & Marx, N. (2010) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-010-0180-7

Drug safety and effectiveness in relation to kidney function : a pharmacoepidemiological approach

Trevisan, M. (2021) · Figshare

Electrolyte disturbances in heart failure

Beusekamp, J. C. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.196047233

Faculty Opinions recommendation of Renal tubular acidosis and management strategies: A narrative review.

Kraut, J. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.740044337.793587491

Extension of Healthy Life Span of Dialysis Patients in the Era of a 100-Year Life

Inaba, M., & Mori, K. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-2345-3

Drugs Used to Treat Hypertension, Heart Failure, and Angina Pectoris

(2009) · Elsevier eBooks · doi:10.1016/b978-0-444-53268-8.50004-1

Potassium Disorders

Sprigings, D. C., & Chambers, J. B. (2007) · Wiley eBooks · doi:10.1002/9780470691885.ch70

Medikamentöse Herzinsuffizienztherapie

Bewarder, Y., Ewen, S., Kindermann, I., & Böhm, M. (2017) · CardioVasc · doi:10.1007/s15027-017-1052-x

Faculty Opinions recommendation of Systematic Review and Meta-Analysis of Patiromer and Sodium Zirconium Cyclosilicate: A New Armamentarium for the Treatment of Hyperkalemia.

Ruilope, L. M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727241641.793564586

Nierenerkrankungen

Reister, B., & Keller, F. (2013) · Springer eBooks · doi:10.1007/978-3-642-40720-8_8

Aggressive treatment is essential to reduce cardiovascular risk in diabetic hypertensive patients

&NA; (2009) · Drugs & Therapy Perspectives · doi:10.2165/11204030-000000000-00000

Systematic Review Of Hyperkalemia Due To Angiotensin Enzyme Converting Inhibitors

Aggarwal, S., Topaloglu, H., & Kumar, S. (2015) · Value in Health · doi:10.1016/j.jval.2015.09.898

Systematic Review of Burden of Hyperkalemia due to Angiotensin Enzyme Converting Inhibitors

Aggarwal, S., Kumar, S., & Topaloglu, H. (2016) · Value in Health · doi:10.1016/j.jval.2016.03.082

Hyperkalemia and Inhibitors of the Renin–Angiotensin–Aldosterone System

Segal, A. Z. (2004) · New England Journal of Medicine · doi:10.1056/nejm200412023512321 · Cited by 2

Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Closer Look at Hyperkalemia

Chung, S., & Park, C. W. (2011) · The Korean Journal of Internal Medicine

Hyperkalemia Associated with Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

Raebel, M. A. (2011) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00258.x · Cited by 190